Koho Lapaʻau ʻAʻole Hoʻokaʻawale i kēia manawa no nā maʻi maʻi ʻili maʻamau

Ma kahi o 3.3 miliona ʻAmelika e ʻike ʻia me ka maʻi maʻi ʻili basal a i ʻole squamous cell skin cancer i kēia makahiki, a hoʻokahi i loko o ʻehā e loaʻa i ka pae kalana ke kiʻi i ka Image-Guided Superficial Radiotherapy (Image-Guided SRT), kahi mea ʻokoʻa ʻole i ke kaʻina Mohs i hana ʻia. Loaʻa i nā dermatologists a puni ka ʻāina e SkinCure Oncology.

Ua ʻike ʻo Kerwin J. Brandt, ka luna hoʻokō nui o SkinCure Oncology, ke hana nei kāna hui me ka ʻoi aku o 200 mau hana dermatology ma 34 mau mokuʻāina, a e hoʻonui wikiwiki ana, e hoʻohui ana i kahi kokoke i 10 mau wahi hou i ka mahina. Hāʻawi ka hui i ka ʻenehana Image-Guided SRT i kāna mau hoa hoʻomaʻamaʻa dermatologist, me kahi hui o nā lawelawe lapaʻau, hoʻokele, a me nā lawelawe kākoʻo hana, e lawe i ka mālama maʻi ma waena o ka maʻi no ko lākou maʻi maʻi ʻili nonmelanoma.

ʻO ke kī i ka hāʻawi ʻana o Image-Guided SRT, ma waho aʻe o ka loaʻa ʻana o ka ʻenehana kūpono ma o ka Sensus Healthcare SRT-100 Vision™, ke hāʻawi nei i ka mālama ʻana me ka protocol kūpono a me nā mana maikaʻi e hoʻokō ai i nā hopena lapaʻau kiʻekiʻe. Hāʻawi ʻo SkinCure Oncology, ma o kāna papahana i hoʻāʻo ʻia, i nā hana dermatology i kahi kumu hoʻohālike i hoʻokō ʻia i ka nui o ka lāʻau lapaʻau i hiki ʻole ke loaʻa a like me nā hopena ʻoluʻolu o ka poʻe maʻi.

"I loko o nā makahiki ʻelima i hala aku nei," wahi a Brandt, "ua kauoha mākou i 240 o nā ʻāpana SRT-100 Vision mai Sensus Healthcare a mākou e manaʻo nei he ʻoi aku ma mua o 95 ka nui o nā ʻāpana SRT-100 Vision a lākou i kūʻai aku ai ma ka honua holoʻokoʻa. Akaka, ke hoʻomau nei mākou i kā lākou mea kūʻai aku nui loa a ua helu ʻia ma mua o 65 pakeneka o kā lākou loaʻa kālā i nā makahiki ʻelima i hala. Ua koho mākou e hui pū me Sensus no kekahi kumu koʻikoʻi - ʻaʻole e like me nā mea hoʻolako i nā mea uila i hoʻolālā ʻia e mālama i ka maʻi maʻi ʻili, ua hoʻohui ʻo Sensus i ke alakaʻi kiʻi i loko o ka hoʻolālā ʻana o ka SRT-100 Vision. ʻO kēia ʻenehana, i hui pū ʻia me SkinCure Oncology a me ke akamai, hiki i kā mākou mau hoa hana dermatology ke mālama i nā maʻi me kahi protocol radiotherapy adaptive i ʻoi aku ka maʻalahi ma mua o nā lāʻau lapaʻau e pili ana i ka radiation a ʻoi aku ka maikaʻi o ka mālama ʻana i ka maʻi maʻi ʻili.

Ua hōʻike ʻia kahi noiʻi nui-nui hou i ka Image-Guided SRT i loaʻa ka nui o ka ho'ōla ʻana o 99.3 pākēneka ma waena o nā carcinomas basal a me ka squamous cell carcinomas. "ʻOiai ʻo Mohs ʻokiʻoki, kahi e ʻoki ai ke kauā i nā ʻāpana o ka ʻiʻo a hiki i ka loaʻa ʻana o nā palena maʻemaʻe, ʻaʻole e loaʻa kēlā mau hopena," wahi a Josh Swindle, ka luna hoʻomaʻamaʻa aupuni o SkinCure Oncology.

Ua hoʻohui ʻo Adam Lefton, ka luna hoʻonaʻauao a me ka luna hoʻonaʻauao, "ʻO nā hopena lapaʻau kiʻekiʻe a me ka hoʻonui wikiwiki ʻana i ka wāwae he mea nui e noʻonoʻo ai no nā hana e hoʻokō nei i ka Image-Guided SRT, akā he ʻāpana wale nō ia o ka moʻolelo. Ua loaʻa iā mākou nā pane noiʻi mai nā mea maʻi ʻoi aku ma mua o 7,200 ma hope o ka mālama ʻana, a ʻo 99.9 precent i ʻōlelo ʻia ua hauʻoli lāua i kā lākou hoʻoholo e mālama ʻia me Image-Guided SRT a manaʻo lākou i kēlā koho lapaʻau i nā poʻe ʻē aʻe. ʻO ka poʻe me ka maʻi maʻi ʻili e mahalo nui i ka loaʻa ʻana o kahi ʻokoʻa liʻiliʻi loa i ka ʻoki ʻana o Mohs, a ʻo ka hui pū ʻana o nā lako SRT alakaʻi kiʻi mai Sensus me ka hoʻokō honua, nā protocols, a me nā limahana ma o SkinCure Oncology ke hoʻololi nei i ka maka o ka maʻi maʻi ʻili i ka US ”